Suresh Prabhu asks Airbus to make planes in India
Suresh Prabhu says if Airbus decides to make aeroplanes in India, it will lead to job creation and will be a win-win situation for both
New Delhi: Civil aviation minister Suresh Prabhu has asked aircraft manufacturer Airbus to build planes in India under the ‘Make in India’ initiative and contribute to the country’s growing aviation sector.
Prabhu visited the Airbus facility in Toulouse on Friday during his ongoing visit to France and said that if Airbus decides to make aeroplanes in India, it will lead to job creation and will be a win-win situation for both.
“Visited the Airbus facility in Toulouse, France. Growing Indian aviation sector, stress on regional connectivity leading to more demand. It is also an opportunity for global aircraft manufacturers,” the minister tweeted after the visit. “Impressed upon them to Make In India. We will work on a roadmap,” the minister said.
Airbus, at present, has more than 300 aircraft flying in the Indian skies and another 530 have been ordered by Indian carriers. Talking to PTI recently, the minister had said: “I will be meeting top bosses of Airbus and try to request them to start manufacturing aircrafts in India”. Airbus Commercial Aircraft, India President Srinivasan Dwarakanath, had in March, on the sidelines of the Wings India aviation event in Hyderabad, said that Airbus will be delivering one plane on an average per week to airlines in India over the next 10 years.
The company in its India market forecast estimated that the country would need 1,750 new aircraft over the next 20 years (2017-2036), comprising 1,320 single-aisle and 430 wide-body planes, valued at $255 billion. The Indian Embassy in France too tweeted about Prabhu’s visit to the facility and said the minister saw passenger planes being built at Toulouse.
- Write-offs at PSBs grow at faster clip than loan growth
- Monetary policy panel cites inflationary risks as reason for RBI rate hike
- Vivo invests ₹200 crore to ramp up manufacturing at Greater Noida facility
- Ad agency Rediffusion to launch new logo, vision
- CSIR lab develops potential clot buster drug for stroke, licences it for clinical trials
Editor's Picks »
- At opposition meet, Rahul Gandhi targets govt over Rafale deal
- News in numbers: Trump’s attacks on the press ‘dangerous to the lifeblood of democracy’, says NYT
- Former Religare CEO Shachindra Nath raises about ₹1,000 crore for NBFC
- PE industry lobbies CCI for anti-trust exemptions
- Opinion | Turkey flashes warning sign to Asia
- Recent rise in trade deficit is not due to the oil prices
- Safeguard duty proposal has deepened uncertainty in the solar energy sector
- Fortis Healthcare: What now, after IHH entry and June quarter loss?
- Weak Q1 for Amara Raja but investors pin hopes on softening lead prices
- IDBI Bank Q1 results show how expensive it is for LIC